Hajime Senjo to Japan
This is a "connection" page, showing publications Hajime Senjo has written about Japan.
Connection Strength
0.235
-
Simultaneous Presentation of Giant Cell Arteritis and Myelodysplastic Syndrome in an Elderly Japanese Man. Intern Med. 2018 Oct 01; 57(19):2889-2893.
Score: 0.135
-
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group. Haematologica. 2024 11 01; 109(11):3631-3640.
Score: 0.053
-
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan. Int J Clin Oncol. 2023 Jun; 28(6):816-826.
Score: 0.047